講演・口頭発表等 - 平川　晃弘

81. Yamamoto H, Tamura K, Tsuda H, Kobayashi T, Hirakawa A, Shimizu C, Kinoshita, Yunokawa M, Koizumi F, Masutomi K, Yonemori K, Ando M, Katsumata N, Fujiwara Y. . Nucleostemin as a predictive marker of pathologic complete response in neoadjuvant chemotherapy for breast cancer: a new biomarker of cancer stem cell and promoter of cell proliferation and tumorigenicity. . 22nd International Congress on Anti Cancer Treatment 2011.02.01

82. Yamamoto H, Yonemori K, Hirakawa A, Shimizu C, Ando M, Katsumata N, Tamura K, Kinoshita T, Tsuda H, Fujiwara Y.. Prognosis of elderly breast cancer patients with intermediate or high risk who received suboptimal adjuvant therapy. . European Society for Medical Oncology Congress 2010.10.08

83. Hirakawa A, Hamada C, Yoshimura I.. A practical comparison of response-adaptive randomizations in clinical trials with binary responses.. 31th International Society of Clinical Biostatistics 2010.08.29

84. Hirakawa A, Hamada C, Yoshimura I. . Sample size calculation through the incorporation of heteroscedasticity and dependence for a penalized t-statistic in microarray experiments. . 31th International Society of Clinical Biostatistics 2010.08.29

85. Hirata T, Yonemori K, Ando M, Hirakawa A, Tsuda H, Hasegawa T, Chuman H, Namikawa K, Yamazaki N, Fujiwara Y. . Efficacy of taxane regimens in patients with metastatic angiosarcoma. . 21st International Congress on Anti-cancer Treatment 2010.02.01

86. Yonemori K, Hirakawa A, Komiyama N, Kouno T, Ando M, Fujiwara Y, Urano T, Akagawa H, Maruyama H, Toyoshima S.. Participation of elderly patients in registered clinical trials for cancer drug applications in Japan. . The 10th Meeting of the International Society of Geriatric Oncology 2009.10.15

87. Kotani N, Katsumata N, Yonemori K, Hirakawa A, Yamamoto H, Ono M, Hirata T, Yunokawa M, Kouno T, Shimizu C, Tamura K, Fujiwara Y. . Feasibility, efficacy and toxicity of carboplatin and paclitaxel as a first-line treatment in elderly patients with ovarian cancer. . The 10th Meeting of the International Society of Geriatric Oncology 2009.10.15

88. Hashimoto K, Yonemori K, Shimizu C, Hirakawa A, Yamamoto H, Ono M, Hirata T, Kouno T, Tamura K, Katsumata N, Fujiwara Y. . Identification of clinical decision making factors in the treatment of geriatric patients with metastatic or recurrent breast cancer.. The 10th Meeting of the International Society of Geriatric Oncology 2009.10.15

89. Hashimoto K, Yonemori K, Katsumata N, Hirakawa A, Shimizu C, Hirata T, Kouno T, Tamura K, Ando M, Fujiwara Y.. Prediction of progressive disease using tumor marker in breast cancer patients without target lesion in first-line chemotherapy.. ASCO Breast Cancer Symposium 2009.10.08

90. Hirata T, Yonemori K, Hirakawa A, Kouno T, Shimizu C, Tamura K, Ando M, Katsumata N, Fujiwara Y.. A retrospective comparison of pleural progression free survival between systemic therapy alone and pleurodesis followed by preceding systemic therapy in breast cancer patients with malignant pleural effusion. . ASCO Breast Cancer Symposium 2009.10.08

91. Hirakawa A, Hamada C, Yoshimura I. . Sample size calculation for a regularized t-statistic in microarray experiments.. 30th International Society of Clinical Biostatistics 2009.08.23

92. Hirakawa A, Sato Y, Hamada C, Yoshimura I.. An adjusted test statistic based on shrunken sample variance for identifying differentially expressed genes in microarray experiments. . XX IVth International Biometric Conference 2008.07.13

93. Hirakawa A, Sato Y, Hamada C, Yoshimura I.. A test statistic based on shrunken sample variance for identifying differentially expressed genes in microarray data analysis.. 1st East Asia Regional Biometrics Conference 2007.12.09

94. Hirakawa A, Sato Y, Hamada C, Yoshimura I. . A statistical method to estimate sensitivity and specificity for identifying marker genes with microarray data. . 28th International Society of Clinical Biostatistics 2007.07.29

95. Hirakawa A, Sato Y, Sozu T, Hamada C, Yoshimura I.. Estimating the false discovery rate using a normal mixture distribution with microarray data.. XX III International Biometric Conference 2006.06.16

96. Sato Y, Ando H, Hirakawa A, Suganami H, Hamada C, Yoshimura I, Yoshida T, Yoshimura K. . Multiple imputation method for SNP typing data in linkage disequilibrium mapping of polygenic traits. . Joint Statistical Meetings 2005.08.07

97. 小戝 健一郎, 永野 聡, 松田 恵理子, 西川路 侑耶, 三井 薫, 川上 広高, 渡邉 真季, 二川 俊隆, 山口 宗一, 橋口 照人, 谷口 昇, 平川 晃弘, 平岡 弘二, 岩田 慎太郎, 川井 章. がん診療における遺伝子治療・細胞治療・再生医療の役割　腫瘍溶解性ウイルスの独自技術の創出と早期承認を目指した非臨床・臨床開発. 日本癌治療学会学術集会抄録集 2024.10.01

98. 橋詰 淳, 山田 晋一郎, 伊藤 大輔, 岸本 祥之, 小森 祥太, 川瀬 崇広, 近藤 綾乃, 花澤 遼一, 佐藤 宏征, 平川 晃弘, 森田 光哉, 山本 知孝, 勝野 雅央. 医療データに基づいた球脊髄性筋萎縮症に対するリュープロレリン酢酸塩の有効性評価. 臨床神経学 2024.10.01

99. 新井 聡大, 花岡 まりえ, 山内 慎一, 馬場 裕信, 花澤 遼一, 佐藤 宏征, 平川 晃弘, 徳永 正則, 絹笠 祐介. 左側結腸/直腸癌に対する患者忍容性の高い腸管前処置の多施設ランダム化非劣性研究. 日本消化器外科学会総会 2024.07.01

100. 菊池 寛昭, 蘇原 映誠, 平川 晃弘, 森 雄太郎, 森 崇寧, 飯盛 聡一郎, 内藤 省太郎, 伏見 清秀, 内田 信一. ビグアナイド薬内服はCOVID-19患者における急性腎障害の低発症率,低死亡率に関与する　日本全国規模調査. 日本腎臓学会誌 2024.06.01